Cargando…

Decreased memory B cell frequencies in COVID‐19 delta variant vaccine breakthrough infection

The SARS‐CoV‐2 Delta (B.1.617.2) variant is capable of infecting vaccinated persons. An open question remains as to whether deficiencies in specific vaccine‐elicited immune responses result in susceptibility to vaccine breakthrough infection. We investigated 55 vaccine breakthrough infection cases (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tay, Matthew Zirui, Rouers, Angeline, Fong, Siew‐Wai, Goh, Yun Shan, Chan, Yi‐Hao, Chang, Zi Wei, Xu, Weili, Tan, Chee Wah, Chia, Wan Ni, Torres‐Ruesta, Anthony, Amrun, Siti Naqiah, Huang, Yuling, Hor, Pei Xiang, Loh, Chiew Yee, Yeo, Nicholas Kim‐Wah, Wang, Bei, Ngoh, Eve Zi Xian, Salleh, Siti Nazihah Mohd, Chavatte, Jean‐Marc, Lim, Alicia Jieling, Maurer‐Stroh, Sebastian, Wang, Lin‐Fa, Lin, Raymond Valentine Tzer Pin, Wang, Cheng‐I, Tan, Seow‐Yen, Young, Barnaby Edward, Leo, Yee‐Sin, Lye, David C, Renia, Laurent, Ng, Lisa FP
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899913/ https://www.ncbi.nlm.nih.gov/pubmed/34994081 http://dx.doi.org/10.15252/emmm.202115227

Ejemplares similares

Resistance of SARS-CoV-2 Delta variant to neutralization by BNT162b2-elicited antibodies in Asians
por: Wang, Bei, et al.
Publicado: (2021)

Third dose of BNT162b2 improves immune response in liver transplant recipients to ancestral strain but not Omicron BA.1 and XBB
por: Chang, Zi Wei, et al.
Publicado: (2023)

Higher Delta variant-specific neutralizing antibodies prevented infection in close contacts vaccinated with ancestral mRNA vaccines during the SARS-CoV-2 Delta wave
por: Goh, Yun Shan, et al.
Publicado: (2023)

Resistance of SARS-CoV-2 variants to neutralization by convalescent plasma from early COVID-19 outbreak in Singapore
por: Wang, Bei, et al.
Publicado: (2021)

Heterologous mRNA vaccine boosters induce a stronger and longer-lasting antibody response against Omicron XBB variant
por: Tay, Matthew Zirui, et al.
Publicado: (2023)

Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose
por: Renia, Laurent, et al.
Publicado: (2022)

Sensitive detection of total anti-Spike antibodies and isotype switching in asymptomatic and symptomatic individuals with COVID-19
por: Goh, Yun Shan, et al.
Publicado: (2021)

Heterologous booster vaccination with CoronaVac following prime vaccination with mRNA vaccine
por: Goh, Yun Shan, et al.
Publicado: (2022)

Human neutralising antibodies elicited by SARS‐CoV‐2 non‐D614G variants offer cross‐protection against the SARS‐CoV‐2 D614G variant
por: Lee, Cheryl Yi‐Pin, et al.
Publicado: (2021)

Waning of specific antibodies against Delta and Omicron variants five months after a third dose of BNT162b2 SARS-CoV-2 vaccine in elderly individuals
por: Goh, Yun Shan, et al.
Publicado: (2022)

Persistent Symptoms and Association With Inflammatory Cytokine Signatures in Recovered Coronavirus Disease 2019 Patients
por: Ong, Sean Wei Xiang, et al.
Publicado: (2021)

Malaria abrogates O’nyong–nyong virus pathologies by restricting virus infection in nonimmune cells
por: Torres-Ruesta, Anthony, et al.
Publicado: (2022)

Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity
por: Amrun, Siti Naqiah, et al.
Publicado: (2020)

Asymptomatic COVID‐19: disease tolerance with efficient anti‐viral immunity against SARS‐CoV‐2
por: Chan, Yi‐Hao, et al.
Publicado: (2021)

Conserved longitudinal alterations of anti-S-protein IgG subclasses in disease progression in initial ancestral Wuhan and vaccine breakthrough Delta infections
por: Goh, Yun Shan, et al.
Publicado: (2022)

Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients
por: Poh, Chek Meng, et al.
Publicado: (2020)

Data-Driven Analysis of COVID-19 Reveals Persistent Immune Abnormalities in Convalescent Severe Individuals
por: Lim, Jackwee, et al.
Publicado: (2021)

Novel differential linear B‐cell epitopes to identify Zika and dengue virus infections in patients
por: Amrun, Siti Naqiah, et al.
Publicado: (2019)

Novel differential linear B‐cell epitopes to identify Zika and dengue virus infections in patients
por: Amrun, Siti Naqiah, et al.
Publicado: (2020)

Systematic analysis of disease‐specific immunological signatures in patients with febrile illness from Saudi Arabia
por: Kam, Yiu‐Wing, et al.
Publicado: (2020)

B-cell ELISpot assay to analyze human memory B cell and plasmablast responses specific to SARS-CoV-2 receptor-binding domain
por: Rouers, Angeline, et al.
Publicado: (2023)

Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant Infection
por: Fong, Siew-Wai, et al.
Publicado: (2021)

Correction to: Robust Virus‐Specific Adaptive Immunity in COVID‐19 Patients with SARS‐CoV‐2 Δ382 Variant Infection
por: Fong, Siew‐Wai, et al.
Publicado: (2021)

Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study
por: Chia, Po Ying, et al.
Publicado: (2022)

Whole blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early marker for severe COVID-19
por: Carissimo, Guillaume, et al.
Publicado: (2020)

Occurrence of 4 Dengue Virus Serotypes and Chikungunya Virus in Kilombero Valley, Tanzania, During the Dengue Outbreak in 2018
por: Chipwaza, Beatrice, et al.
Publicado: (2020)

Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study
por: Young, Barnaby E, et al.
Publicado: (2020)

Virus infection drives IL-2 antibody complexes into pro-inflammatory agonists in mice
por: Lee, Wendy W. L., et al.
Publicado: (2016)

Cross-reactive dengue human monoclonal antibody prevents severe pathologies and death from Zika virus infections
por: Kam, Yiu-Wing, et al.
Publicado: (2017)

Comprehensive engineering of a therapeutic neutralizing antibody targeting SARS-CoV-2 spike protein to neutralize escape variants
por: Kuramochi, Taichi, et al.
Publicado: (2022)

Safety and potential efficacy of cyclooxygenase‐2 inhibitors in coronavirus disease 2019
por: Ong, Sean Wei Xiang, et al.
Publicado: (2020)

Mutating chikungunya virus non‐structural protein produces potent live‐attenuated vaccine candidate
por: Chan, Yi‐Hao, et al.
Publicado: (2019)

Tumor-mediated microbiota alteration impairs synaptic tagging/capture in the hippocampal CA1 area via IL-1β production
por: Zhu, Ying, et al.
Publicado: (2023)

Immunological observations and transcriptomic analysis of trimester‐specific full‐term placentas from three Zika virus‐infected women
por: Lum, Fok‐Moon, et al.
Publicado: (2019)

Discovery and Genomic Characterization of a 382-Nucleotide Deletion in ORF7b and ORF8 during the Early Evolution of SARS-CoV-2
por: Su, Yvonne C. F., et al.
Publicado: (2020)

Plasmodium co-infection protects against chikungunya virus-induced pathologies
por: Teo, Teck-Hui, et al.
Publicado: (2018)

Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational study
por: Young, Barnaby E, et al.
Publicado: (2021)

Lack of cross-neutralization by SARS patient sera towards SARS-CoV-2
por: Anderson, Danielle E., et al.
Publicado: (2020)

Multimodal assessments of Zika virus immune pathophysiological responses in marmosets
por: Lum, Fok-Moon, et al.
Publicado: (2018)

Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Efficacy of Remdesivir
por: Chan, Yi-Hao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v8ikrfp8s7o02skdc7shfi8ste